Skip to main content
  • Login
  • Contact
  • Subscribe
  • Advertise With Us

Search form

Home

The Pilot News

Plymouth weather info

  • Home
    • Forms
  • News
    • Local News
    • The Leader of Starke County
    • Culver Citizen
    • Business News
  • Sports
  • Obituaries
  • Classifieds
    • Place an Ad
    • Classified Display Ads
  • Entertainment
    • Calendar
    • Best Of
    • Special Sections
    • Talking About...
    • Games
  • Photos
  • Videos
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
United Therapeutic (NQ: UTHR)
81.67 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 5:02 PM EDT, Oct 17, 2019  /  Add to My Watchlist      
View: Quote
Overview
Detailed Quote
Charting
Historical Prices
 News
All News
Press Releases
Related Stories
Blogs
 Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 81.67
Bid (Size) 81.58 (12)
Ask (Size) 81.67 (3)
Prev. Close 81.67
Today's Range 81.67 - 81.67
52wk Range 74.31 - 128.94
Shares Outstanding 43,544,022
Dividend Yield N/A
Performance
YTD
-24.13%
-24.13%
1 Month
-4.89%
-4.89%
3 Month
+7.11%
+7.11%
6 Month
-18.61%
-18.61%
1 Year
-35.69%
-35.69%
Top News
More News
Respira Therapeutics Regains North America Rights from United Therapeutics to Phase 2 Inhaled Drug-Device Product, RT234, for Pulmonary Hypertension Indications
October 10, 2019
Respira Therapeutics, a clinical-stage specialty pharmaceutical company developing next-generation cardiopulmonary disease-targeted inhalation products, has regained full worldwide research,... Read More
from PR Newswire
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
September 12, 2019
from PR Newswire
More News
Read More
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
September 11, 2019
from PR Newswire
iBio Inks 3D Bioprinting Agreement
August 19, 2019
from GlobeNewswire News Releases
Correvio Reports Second Quarter 2019 Financial Results
August 14, 2019
from PR Newswire
United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference
August 06, 2019
from PR Newswire
United Therapeutics Corporation Reports Second Quarter 2019 Financial Results
July 31, 2019
from PR Newswire
United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019
July 24, 2019
from PR Newswire
FBT, ACAD, UTHR, NBIX: ETF Outflow Alert
September 26, 2019
category ETFs
from ETF Channel
How The Pieces Add Up: VLU Headed For $116
September 19, 2019
category ETFs
from ETF Channel
Analysts Predict 13% Upside For The Holdings of RXL
August 19, 2019
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2019 The Pilot News | 214 N. Michigan | Plymouth, IN 46563 | (574) 936-3101 • 800-933-0356
All property rights for the entire contents of this publication shall be the property of The Pilot News.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media